001540 — AHN-GOOK PHARMACEUTICAL Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual income statement for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	143,364	163,534	205,389	233,676	271,116
Cost of Revenue
Gross Profit	84,893	101,018	126,279	140,571	167,896
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	143,425	164,618	196,221	228,679	264,634
Operating Profit	-61.2	-1,084	9,167	4,997	6,482
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	778	3,805	7,375	4,267	20,239
Provision for Income Taxes
Net Income After Taxes	-1,388	3,744	6,879	998	16,343
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,315	3,939	6,875	1,290	16,845
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,315	3,939	6,875	1,290	16,845
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-111	332	644	116	559
Dividends per Share